AAAAAA
Results:
1-19
|
Results: 19
Authors:
Buhring, U
Herrlinger, U
Krings, T
Thiex, R
Weller, M
Kuker, W
Citation: U. Buhring et al., MRI features of primary central nervous system lymphomas at presentation, NEUROLOGY, 57(3), 2001, pp. 393-396
Authors:
Aboody, KS
Brown, A
Rainov, NG
Bower, KA
Liu, SX
Yang, W
Small, JE
Herrlinger, U
Ourednik, V
Black, PM
Breakefield, XO
Snyder, EY
Citation: Ks. Aboody et al., Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas (vol 97, pg 12846, 2000), P NAS US, 98(2), 2001, pp. 777-777
Authors:
Jacobs, A
Tjuvajev, JG
Dubrovin, M
Akhurst, T
Balatoni, J
Beattie, B
Joshi, R
Finn, R
Larson, SM
Herrlinger, U
Pechan, PA
Chiocca, EA
Breakefield, XO
Blasberg, RG
Citation: A. Jacobs et al., Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo, CANCER RES, 61(7), 2001, pp. 2983-2995
Authors:
Herrlinger, U
Schabet, M
Brugger, W
Kortmann, RD
Kanz, L
Bamberg, M
Dichgans, J
Weller, M
Citation: U. Herrlinger et al., Primary central nervous system lymphoma 1991-1997 - Outcome and late adverse effects after combined modality treatment, CANCER, 91(1), 2001, pp. 130-135
Authors:
Herrlinger, U
Schabet, M
Brugger, W
Kortmann, RD
Kanz, L
Bamberg, M
Dichgans, J
Weller, M
Citation: U. Herrlinger et al., Primary central nervous system lymphoma 1991-1997 - Outcome and late adverse effects after combined modality treatment, CANC CYTOP, 91(1), 2001, pp. 130-135
Authors:
Herrlinger, U
Woiciechowski, C
Sena-Esteves, M
Aboody, KS
Jacobs, AH
Rainov, NG
Snyder, EY
Breakefield, XO
Citation: U. Herrlinger et al., Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas, MOL THER, 1(4), 2000, pp. 347-357
Authors:
Herrlinger, U
Pechan, PA
Jacobs, AH
Woiciechowski, C
Rainov, NG
Fraefel, C
Paulus, W
Reeves, SA
Citation: U. Herrlinger et al., HSV-1 infected cell proteins influence tetracycline-regulated transgene expression, J GENE MED, 2(5), 2000, pp. 379-389
Authors:
Herrlinger, U
Jacobs, A
Quinones, A
Woiciechowsky, C
Sena-Esteves, M
Rainov, NG
Fraefel, C
Breakefield, XO
Citation: U. Herrlinger et al., Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma, HUM GENE TH, 11(10), 2000, pp. 1429-1438
Authors:
Herrlinger, U
Weller, M
Dichgans, J
Melms, A
Citation: U. Herrlinger et al., Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?, ANN NEUROL, 47(5), 2000, pp. 682-683
Authors:
Schmidt, F
Wick, W
Herrlinger, U
Dichgans, J
Weller, M
Citation: F. Schmidt et al., Treosulfan chemotherapy for recurrent malignant glioma, J NEURO-ONC, 49(3), 2000, pp. 231-234
Authors:
Herrlinger, U
Brugger, W
Bamberg, M
Kuker, W
Dichgans, J
Weller, M
Citation: U. Herrlinger et al., PCV salvage chemotherapy for recurrent primary CNS lymphoma, NEUROLOGY, 54(8), 2000, pp. 1707-1708
Authors:
Aboody, KS
Brown, A
Rainov, NG
Bower, KA
Liu, SX
Yang, W
Small, JE
Herrlinger, U
Ourednik, V
Black, PM
Breakefield, XO
Snyder, EY
Citation: Ks. Aboody et al., Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas, P NAS US, 97(23), 2000, pp. 12846-12851
Authors:
Herrlinger, U
Klingel, K
Meyermann, R
Kandolf, R
Kaiserling, E
Kortmann, RD
Melms, A
Skalej, M
Dichgans, J
Weller, M
Citation: U. Herrlinger et al., Central nervous system Hodgkin's lymphoma without systemic manifestation: case report and review of the literature, ACT NEUROP, 99(6), 2000, pp. 709-714
Authors:
Herrlinger, U
Jacobs, A
Aghi, M
Schuback, DE
Breakefield, XO
Citation: U. Herrlinger et al., HSV-1 vectors for gene therapy of experimental CNS tumors, METH MOL M, 35, 2000, pp. 287-312
Authors:
Pechan, PA
Herrlinger, U
Aghi, M
Jacobs, A
Breakefield, XO
Citation: Pa. Pechan et al., Combined HSV-1 recombinant and amplicon piggyback vectors: Replication-competent and defective forms, and therapeutic efficacy for experimental gliomas, J GENE MED, 1(3), 1999, pp. 176-185
Authors:
Rainov, NG
Ikeda, K
Qureshi, NH
Grover, S
Herrlinger, U
Pechan, P
Chiocca, EA
Breakefield, XO
Barnett, FH
Citation: Ng. Rainov et al., Intraarterial delivery of adenovirus vectors and liposome-DNA complexes toexperimental brain neoplasms, HUM GENE TH, 10(2), 1999, pp. 311-318
Authors:
Herrlinger, U
Schabet, M
Bitzer, M
Petersen, D
Krauseneck, P
Citation: U. Herrlinger et al., Primary central nervous system lymphoma: From clinical presentation to diagnosis, J NEURO-ONC, 43(3), 1999, pp. 219-226
Authors:
Herrlinger, U
Citation: U. Herrlinger, Primary CNS lymphoma: Findings outside the brain, J NEURO-ONC, 43(3), 1999, pp. 227-230
Authors:
Herrlinger, U
Schmidberger, H
Buchholz, R
Wehrmann, M
Vallera, DA
Schabet, M
Citation: U. Herrlinger et al., Intrathecal therapy of leptomeningeal CEM T-cell lymphoma in nude rats with anti-CD7 ricin toxin A chain immunotoxin, J NEURO-ONC, 40(1), 1998, pp. 1-9
Risultati:
1-19
|